Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
Submitted by
admin
on August 4, 2010 - 7:42am
Source:
Yahoo/AP
News Tags:
GSK
licensing
Five Prime
Headline:
GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
Do Not Allow Advertisers to Use My Personal information
